151751-Najiba-Chargi

50 CHAPTER 3 REFERENCES 1. Mintziras I, Miligkos M, Wachter S, Manoha - ran J, Maurer E, Bartsch DK. Sarcopenia and sarcopenic obesity are significantly associ- ated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis. Int J Surg . 2018; 59:19- 26. doi: S1743-9191(18)31637-6 [pii]. 2. Kamarajah SK, Bundred J, Tan BHL. Body composition assessment and sarcopenia in patients with gastric cancer: A systematic review and meta-analysis. Gastric Cancer. 2019;22(1):10-22. doi: 10.1007/s10120-018- 0882-2 [doi]. 3. Limpawattana P, Theerakulpisut D, Wirasorn K, Sookprasert A, Khuntikeo N, Chindaprasirt J. The impact of skele - tal muscle mass on survival outcome in biliary tract cancer patients. PLoS One. 2018;13(10):e0204985. doi: 10.1371/journal. pone.0204985 [doi]. 4. Kurita Y, Kobayashi N, Tokuhisa M, et al. Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherapy. Pan- creatology . 2019;19(1):127-135. doi: S1424- 3903(18)30746-4 [pii]. 5. Hua H, Xu X, Tang Y, Ren Z, Xu Q, Chen L. Effect of sarcopenia on clinical outcomes following digestive carcinoma surgery: A meta-analysis. Support Care Cancer . 2019. doi: 10.1007/s00520-019-04767-4 [doi]. 6. Tamura T, Sakurai K, Nambara M, et al. Adverse effects of preoperative sarcope - nia on postoperative complications of pa- tients with gastric cancer. Anticancer Res. 2019;39(2):987-992. doi: 10.21873/antican - res.13203 [doi]. 7. Wendrich AW, Swartz JE, Bril SI, et al. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer. Oral Oncol . 2017; 71:26-33. doi: S1368-8375(17)30129-X [pii]. 8. Ganju RG, Morse R, Hoover A, TenNapel M, Lominska CE. The impact of sarcope - nia on tolerance of radiation and out- come in patients with head and neck cancer receiving chemoradiation. Radio- ther Oncol . 2019;137:117-124. doi: S0167- 8140(19)30375-5 [pii]. 9. Bril SI, Pezier TF, Tijink BM, Janssen LM, Braunius WW, de Bree R. Preoperative low skeletal muscle mass as a risk factor for pharyngocutaneous fistula and decreased overall survival in patients undergoing total laryngectomy. Head Neck . 2019. doi: 10.1002/hed.25638 [doi]. 10. AchimV, Bash J, Mowery A, et al. Prognostic indication of sarcopenia for wound compli- cation after total laryngectomy. JAMA Oto- laryngol Head Neck Surg. 2017;143(12):1159- 1165. doi: 10.1001/jamaoto.2017.0547 [doi]. 11. Chargi N, Bril SI, Emmelot-Vonk MH, de Bree R. Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer. Eur Arch Otorhi- nolaryngol . 2019;276(5):1475-1486. doi: 10.1007/s00405-019-05361-4 [doi]. 12. Tamaki A, Manzoor NF, Babajanian E, Ascha M, Rezaee R, Zender CA. Clinical signifi - cance of sarcopenia among patients with advanced oropharyngeal cancer. Otolaryn- gol Head Neck Surg . 2019;160(3):480-487. doi: 10.1177/0194599818793857 [doi]. 13. Fattouh M, Chang GY, Ow TJ, et al. Associ - ation between pretreatment obesity, sar- copenia, and survival in patients with head and neck cancer. Head Neck . 2019;41(3):707- 714. doi: 10.1002/hed.25420 [doi]. 14. Nordez A, Jolivet E, Sudhoff I, Bonneau D, de Guise JA, Skalli W. Comparison of meth - ods to assess quadriceps muscle volume using magnetic resonance imaging. J Magn Reson Imaging . 2009;30(5):1116-1123. doi: 10.1002/jmri.21867 [doi].